This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for December 2023. We discuss several civil and criminal enforcement actions that involve alleged violations of the False...more
2/1/2024
/ Advisory Opinions ,
Anti-Kickback Statute ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
False Claims Act (FCA) ,
Healthcare ,
Legislative Agendas ,
OIG ,
Regulatory Agenda ,
Regulatory Requirements ,
Regulatory Violations
The US Department of Health and Human Services Office of Inspector General (OIG) recently issued Advisory Opinion (AO) 23-03, analyzing a proposed arrangement in which a company that manufactures an at-home colon cancer...more